nodes	percent_of_prediction	percent_of_DWPC	metapath
Decitabine—DNMT3A—embryo—ovarian cancer	0.0169	0.0688	CbGeAlD
Decitabine—DNMT3A—decidua—ovarian cancer	0.013	0.0531	CbGeAlD
Decitabine—DNMT3A—RMTs methylate histone arginines—WDR77—ovarian cancer	0.0126	0.0741	CbGpPWpGaD
Decitabine—DNMT3A—gonad—ovarian cancer	0.0114	0.0467	CbGeAlD
Decitabine—DNMT1—myometrium—ovarian cancer	0.0106	0.0433	CbGeAlD
Decitabine—DNMT3A—female reproductive system—ovarian cancer	0.0102	0.0417	CbGeAlD
Decitabine—DNMT1—embryo—ovarian cancer	0.0102	0.0416	CbGeAlD
Decitabine—DNMT3A—female gonad—ovarian cancer	0.0093	0.038	CbGeAlD
Decitabine—DNMT3A—vagina—ovarian cancer	0.00924	0.0377	CbGeAlD
Decitabine—DNMT1—epithelium—ovarian cancer	0.00832	0.034	CbGeAlD
Decitabine—DNMT1—uterine cervix—ovarian cancer	0.00825	0.0337	CbGeAlD
Decitabine—DNMT3A—testis—ovarian cancer	0.00825	0.0337	CbGeAlD
Decitabine—DNMT3A—RMTs methylate histone arginines—ARID1A—ovarian cancer	0.00813	0.0478	CbGpPWpGaD
Decitabine—DNMT1—decidua—ovarian cancer	0.00786	0.0321	CbGeAlD
Decitabine—DNMT1—endometrium—ovarian cancer	0.00746	0.0305	CbGeAlD
Decitabine—DCK—Nucleotide metabolism—NME2—ovarian cancer	0.00735	0.0432	CbGpPWpGaD
Decitabine—DCK—myometrium—ovarian cancer	0.00733	0.0299	CbGeAlD
Decitabine—DCK—embryo—ovarian cancer	0.00705	0.0288	CbGeAlD
Decitabine—DNMT1—Vinblastine—Vinorelbine—ovarian cancer	0.00693	0.636	CbGdCrCtD
Decitabine—DNMT1—gonad—ovarian cancer	0.00692	0.0283	CbGeAlD
Decitabine—Lamivudine—NME2—ovarian cancer	0.0069	0.377	CrCbGaD
Decitabine—DNMT1—uterus—ovarian cancer	0.00687	0.0281	CbGeAlD
Decitabine—DNMT3A—One Carbon Metabolism—TYMS—ovarian cancer	0.00677	0.0398	CbGpPWpGaD
Decitabine—DNMT3A—Epigenetic regulation of gene expression—TTF1—ovarian cancer	0.00671	0.0394	CbGpPWpGaD
Decitabine—DNMT1—female reproductive system—ovarian cancer	0.00618	0.0252	CbGeAlD
Decitabine—DNMT3A—Trans-sulfuration and one carbon metabolism—TYMS—ovarian cancer	0.00608	0.0357	CbGpPWpGaD
Decitabine—DNMT3A—lymph node—ovarian cancer	0.00598	0.0244	CbGeAlD
Decitabine—DNMT1—bone marrow—ovarian cancer	0.00583	0.0238	CbGeAlD
Decitabine—DNMT1—Retinoblastoma (RB) in Cancer—BARD1—ovarian cancer	0.00573	0.0337	CbGpPWpGaD
Decitabine—DCK—uterine cervix—ovarian cancer	0.00571	0.0233	CbGeAlD
Decitabine—DNMT1—female gonad—ovarian cancer	0.00562	0.023	CbGeAlD
Decitabine—DNMT1—vagina—ovarian cancer	0.00559	0.0228	CbGeAlD
Decitabine—DCK—decidua—ovarian cancer	0.00544	0.0222	CbGeAlD
Decitabine—DNMT3A—Chromatin modifying enzymes—WDR77—ovarian cancer	0.00539	0.0317	CbGpPWpGaD
Decitabine—DNMT1—NoRC negatively regulates rRNA expression—TTF1—ovarian cancer	0.00523	0.0307	CbGpPWpGaD
Decitabine—DCK—endometrium—ovarian cancer	0.00516	0.0211	CbGeAlD
Decitabine—DNMT1—Negative epigenetic regulation of rRNA expression—TTF1—ovarian cancer	0.00511	0.03	CbGpPWpGaD
Decitabine—DNMT1—testis—ovarian cancer	0.00499	0.0204	CbGeAlD
Decitabine—DNMT3A—RMTs methylate histone arginines—SMARCA4—ovarian cancer	0.00489	0.0287	CbGpPWpGaD
Decitabine—DNMT3A—Validated targets of C-MYC transcriptional repression—GADD45A—ovarian cancer	0.0048	0.0282	CbGpPWpGaD
Decitabine—DCK—gonad—ovarian cancer	0.00479	0.0195	CbGeAlD
Decitabine—DCK—uterus—ovarian cancer	0.00475	0.0194	CbGeAlD
Decitabine—DCK—Retinoblastoma (RB) in Cancer—BARD1—ovarian cancer	0.00475	0.0279	CbGpPWpGaD
Decitabine—DNMT1—One Carbon Metabolism—TYMS—ovarian cancer	0.00457	0.0269	CbGpPWpGaD
Decitabine—DNMT1—Epigenetic regulation of gene expression—TTF1—ovarian cancer	0.00453	0.0266	CbGpPWpGaD
Decitabine—DCK—Pyrimidine metabolism—TYMS—ovarian cancer	0.00428	0.0252	CbGpPWpGaD
Decitabine—DCK—female reproductive system—ovarian cancer	0.00427	0.0175	CbGeAlD
Decitabine—DNMT3A—Validated targets of C-MYC transcriptional repression—BRCA1—ovarian cancer	0.00411	0.0242	CbGpPWpGaD
Decitabine—DNMT1—Trans-sulfuration and one carbon metabolism—TYMS—ovarian cancer	0.00411	0.0241	CbGpPWpGaD
Decitabine—DCK—bone marrow—ovarian cancer	0.00404	0.0165	CbGeAlD
Decitabine—DCK—female gonad—ovarian cancer	0.00389	0.0159	CbGeAlD
Decitabine—DCK—vagina—ovarian cancer	0.00387	0.0158	CbGeAlD
Decitabine—DNMT1—Regulation of retinoblastoma protein—SMARCA4—ovarian cancer	0.00366	0.0215	CbGpPWpGaD
Decitabine—DNMT1—lymph node—ovarian cancer	0.00361	0.0148	CbGeAlD
Decitabine—Cladribine—NR5A1—ovarian cancer	0.00361	0.197	CrCbGaD
Decitabine—DNMT1—Regulation of retinoblastoma protein—SKP2—ovarian cancer	0.00349	0.0205	CbGpPWpGaD
Decitabine—DNMT3A—Chromatin modifying enzymes—ARID1A—ovarian cancer	0.00347	0.0204	CbGpPWpGaD
Decitabine—DCK—testis—ovarian cancer	0.00345	0.0141	CbGeAlD
Decitabine—Floxuridine—TYMS—ovarian cancer	0.00296	0.162	CrCbGaD
Decitabine—DNMT1—Retinoblastoma (RB) in Cancer—SKP2—ovarian cancer	0.0028	0.0165	CbGpPWpGaD
Decitabine—DNMT1—Regulation of retinoblastoma protein—CCND2—ovarian cancer	0.00268	0.0157	CbGpPWpGaD
Decitabine—DCK—lymph node—ovarian cancer	0.0025	0.0102	CbGeAlD
Decitabine—Trifluridine—TYMS—ovarian cancer	0.00235	0.128	CrCbGaD
Decitabine—DNMT1—Regulation of retinoblastoma protein—CCNE1—ovarian cancer	0.00234	0.0138	CbGpPWpGaD
Decitabine—DCK—Retinoblastoma (RB) in Cancer—SKP2—ovarian cancer	0.00232	0.0136	CbGpPWpGaD
Decitabine—DNMT3A—Chromatin modifying enzymes—SMARCA4—ovarian cancer	0.00209	0.0123	CbGpPWpGaD
Decitabine—DCK—Doxorubicin—Epirubicin—ovarian cancer	0.00206	0.189	CbGdCrCtD
Decitabine—DNMT3A—Validated targets of C-MYC transcriptional repression—ERBB2—ovarian cancer	0.00202	0.0118	CbGpPWpGaD
Decitabine—DCK—Epirubicin—Doxorubicin—ovarian cancer	0.00191	0.175	CbGdCrCtD
Decitabine—DNMT1—Retinoblastoma (RB) in Cancer—CCNE1—ovarian cancer	0.00188	0.011	CbGpPWpGaD
Decitabine—DNMT3A—Validated targets of C-MYC transcriptional repression—CDKN1B—ovarian cancer	0.00187	0.011	CbGpPWpGaD
Decitabine—DNMT1—Retinoblastoma (RB) in Cancer—TYMS—ovarian cancer	0.00185	0.0108	CbGpPWpGaD
Decitabine—DNMT1—Regulation of retinoblastoma protein—MET—ovarian cancer	0.0018	0.0105	CbGpPWpGaD
Decitabine—DNMT3A—Validated targets of C-MYC transcriptional repression—CCND1—ovarian cancer	0.00178	0.0105	CbGpPWpGaD
Decitabine—Gemcitabine—TYMS—ovarian cancer	0.00167	0.0913	CrCbGaD
Decitabine—DCK—Nucleotide metabolism—TYMS—ovarian cancer	0.00167	0.0098	CbGpPWpGaD
Decitabine—DCK—Retinoblastoma (RB) in Cancer—CCNE1—ovarian cancer	0.00156	0.00914	CbGpPWpGaD
Decitabine—DNMT3A—RMTs methylate histone arginines—CCND1—ovarian cancer	0.00155	0.0091	CbGpPWpGaD
Decitabine—DCK—Retinoblastoma (RB) in Cancer—TYMS—ovarian cancer	0.00153	0.00898	CbGpPWpGaD
Decitabine—DNMT3A—Validated targets of C-MYC transcriptional repression—MYC—ovarian cancer	0.00143	0.0084	CbGpPWpGaD
Decitabine—DNMT3A—Gene Expression—WDR77—ovarian cancer	0.00143	0.00839	CbGpPWpGaD
Decitabine—DNMT1—Regulation of retinoblastoma protein—CDKN1B—ovarian cancer	0.00122	0.00714	CbGpPWpGaD
Decitabine—DNMT1—Regulation of retinoblastoma protein—CCND1—ovarian cancer	0.00116	0.00681	CbGpPWpGaD
Decitabine—DNMT3A—Gene Expression—TTF1—ovarian cancer	0.00112	0.00658	CbGpPWpGaD
Decitabine—DNMT3A—Gene Expression—NR5A1—ovarian cancer	0.00102	0.00598	CbGpPWpGaD
Decitabine—DNMT1—Retinoblastoma (RB) in Cancer—CDKN1B—ovarian cancer	0.000974	0.00572	CbGpPWpGaD
Decitabine—DNMT1—Gene Expression—WDR77—ovarian cancer	0.000965	0.00567	CbGpPWpGaD
Decitabine—DNMT1—Retinoblastoma (RB) in Cancer—CCND1—ovarian cancer	0.00093	0.00546	CbGpPWpGaD
Decitabine—DCK—Retinoblastoma (RB) in Cancer—CDKN1B—ovarian cancer	0.000807	0.00474	CbGpPWpGaD
Decitabine—DCK—Retinoblastoma (RB) in Cancer—CCND1—ovarian cancer	0.000769	0.00452	CbGpPWpGaD
Decitabine—DNMT1—Gene Expression—TTF1—ovarian cancer	0.000757	0.00445	CbGpPWpGaD
Decitabine—DNMT1—Retinoblastoma (RB) in Cancer—MYC—ovarian cancer	0.000746	0.00438	CbGpPWpGaD
Decitabine—DNMT1—Gene Expression—NR5A1—ovarian cancer	0.000687	0.00404	CbGpPWpGaD
Decitabine—DCK—Metabolism—NME2—ovarian cancer	0.000668	0.00392	CbGpPWpGaD
Decitabine—DNMT3A—Chromatin modifying enzymes—CCND1—ovarian cancer	0.000662	0.00389	CbGpPWpGaD
Decitabine—DCK—Retinoblastoma (RB) in Cancer—MYC—ovarian cancer	0.000617	0.00363	CbGpPWpGaD
Decitabine—DNMT1—Retinoblastoma (RB) in Cancer—TP53—ovarian cancer	0.000612	0.0036	CbGpPWpGaD
Decitabine—DNMT3A—Gene Expression—YAP1—ovarian cancer	0.00058	0.00341	CbGpPWpGaD
Decitabine—DCK—Retinoblastoma (RB) in Cancer—TP53—ovarian cancer	0.000507	0.00298	CbGpPWpGaD
Decitabine—DNMT3A—Gene Expression—PGR—ovarian cancer	0.000507	0.00298	CbGpPWpGaD
Decitabine—DNMT3A—Gene Expression—PARP1—ovarian cancer	0.000471	0.00277	CbGpPWpGaD
Decitabine—DCK—Metabolism—CYTB—ovarian cancer	0.00043	0.00253	CbGpPWpGaD
Decitabine—Gemcitabine—ABCB1—ovarian cancer	0.000423	0.0231	CrCbGaD
Decitabine—DNMT1—Gene Expression—YAP1—ovarian cancer	0.000392	0.0023	CbGpPWpGaD
Decitabine—Lamivudine—ABCB1—ovarian cancer	0.000385	0.0211	CrCbGaD
Decitabine—DNMT3A—Gene Expression—PPP2R1A—ovarian cancer	0.000382	0.00224	CbGpPWpGaD
Decitabine—DCK—Metabolism—PPP1CC—ovarian cancer	0.000376	0.00221	CbGpPWpGaD
Decitabine—DCK—Metabolism—BRIP1—ovarian cancer	0.000376	0.00221	CbGpPWpGaD
Decitabine—DNMT1—Gene Expression—PGR—ovarian cancer	0.000342	0.00201	CbGpPWpGaD
Decitabine—Nervous system disorder—Paclitaxel—ovarian cancer	0.000338	0.000609	CcSEcCtD
Decitabine—Hypokalaemia—Doxorubicin—ovarian cancer	0.000338	0.000608	CcSEcCtD
Decitabine—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000338	0.000608	CcSEcCtD
Decitabine—Tachycardia—Paclitaxel—ovarian cancer	0.000337	0.000606	CcSEcCtD
Decitabine—Skin disorder—Paclitaxel—ovarian cancer	0.000335	0.000603	CcSEcCtD
Decitabine—Aspartate aminotransferase increased—Doxorubicin—ovarian cancer	0.000334	0.000602	CcSEcCtD
Decitabine—Bronchitis—Epirubicin—ovarian cancer	0.000334	0.0006	CcSEcCtD
Decitabine—Nasopharyngitis—Doxorubicin—ovarian cancer	0.000332	0.000597	CcSEcCtD
Decitabine—Anaemia—Docetaxel—ovarian cancer	0.000331	0.000596	CcSEcCtD
Decitabine—Pancytopenia—Epirubicin—ovarian cancer	0.000329	0.000593	CcSEcCtD
Decitabine—Anorexia—Paclitaxel—ovarian cancer	0.000329	0.000592	CcSEcCtD
Decitabine—Muscular weakness—Doxorubicin—ovarian cancer	0.000327	0.000589	CcSEcCtD
Decitabine—Vomiting—Vinorelbine—ovarian cancer	0.000326	0.000587	CcSEcCtD
Decitabine—Dysuria—Epirubicin—ovarian cancer	0.000324	0.000584	CcSEcCtD
Decitabine—Neutropenia—Epirubicin—ovarian cancer	0.000324	0.000584	CcSEcCtD
Decitabine—Rash—Vinorelbine—ovarian cancer	0.000323	0.000582	CcSEcCtD
Decitabine—Dermatitis—Vinorelbine—ovarian cancer	0.000323	0.000581	CcSEcCtD
Decitabine—Abdominal distension—Doxorubicin—ovarian cancer	0.000323	0.000581	CcSEcCtD
Decitabine—Hypotension—Paclitaxel—ovarian cancer	0.000322	0.00058	CcSEcCtD
Decitabine—Upper respiratory tract infection—Epirubicin—ovarian cancer	0.000322	0.00058	CcSEcCtD
Decitabine—Headache—Vinorelbine—ovarian cancer	0.000321	0.000578	CcSEcCtD
Decitabine—Dysphagia—Doxorubicin—ovarian cancer	0.000321	0.000577	CcSEcCtD
Decitabine—Leukopenia—Docetaxel—ovarian cancer	0.000321	0.000577	CcSEcCtD
Decitabine—Pollakiuria—Epirubicin—ovarian cancer	0.00032	0.000576	CcSEcCtD
Decitabine—DNMT1—Gene Expression—PARP1—ovarian cancer	0.000318	0.00187	CbGpPWpGaD
Decitabine—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000314	0.000566	CcSEcCtD
Decitabine—Weight decreased—Epirubicin—ovarian cancer	0.000314	0.000565	CcSEcCtD
Decitabine—Hyperglycaemia—Epirubicin—ovarian cancer	0.000313	0.000563	CcSEcCtD
Decitabine—Cough—Docetaxel—ovarian cancer	0.000313	0.000563	CcSEcCtD
Decitabine—Insomnia—Paclitaxel—ovarian cancer	0.000312	0.000561	CcSEcCtD
Decitabine—Pneumonia—Epirubicin—ovarian cancer	0.000311	0.00056	CcSEcCtD
Decitabine—Hypertension—Docetaxel—ovarian cancer	0.000309	0.000557	CcSEcCtD
Decitabine—Infestation NOS—Epirubicin—ovarian cancer	0.000309	0.000556	CcSEcCtD
Decitabine—Infestation—Epirubicin—ovarian cancer	0.000309	0.000556	CcSEcCtD
Decitabine—Bronchitis—Doxorubicin—ovarian cancer	0.000309	0.000555	CcSEcCtD
Decitabine—Dyspnoea—Paclitaxel—ovarian cancer	0.000308	0.000553	CcSEcCtD
Decitabine—Chest pain—Docetaxel—ovarian cancer	0.000305	0.000549	CcSEcCtD
Decitabine—Arthralgia—Docetaxel—ovarian cancer	0.000305	0.000549	CcSEcCtD
Decitabine—Myalgia—Docetaxel—ovarian cancer	0.000305	0.000549	CcSEcCtD
Decitabine—Pancytopenia—Doxorubicin—ovarian cancer	0.000305	0.000548	CcSEcCtD
Decitabine—Nausea—Vinorelbine—ovarian cancer	0.000305	0.000548	CcSEcCtD
Decitabine—Renal failure—Epirubicin—ovarian cancer	0.000304	0.000547	CcSEcCtD
Decitabine—Dyspepsia—Paclitaxel—ovarian cancer	0.000304	0.000546	CcSEcCtD
Decitabine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000303	0.000545	CcSEcCtD
Decitabine—Stomatitis—Epirubicin—ovarian cancer	0.000301	0.000542	CcSEcCtD
Decitabine—Urinary tract infection—Epirubicin—ovarian cancer	0.000301	0.000541	CcSEcCtD
Decitabine—Neutropenia—Doxorubicin—ovarian cancer	0.0003	0.00054	CcSEcCtD
Decitabine—Dysuria—Doxorubicin—ovarian cancer	0.0003	0.00054	CcSEcCtD
Decitabine—Decreased appetite—Paclitaxel—ovarian cancer	0.0003	0.00054	CcSEcCtD
Decitabine—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.000298	0.000537	CcSEcCtD
Decitabine—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000298	0.000536	CcSEcCtD
Decitabine—Fatigue—Paclitaxel—ovarian cancer	0.000297	0.000535	CcSEcCtD
Decitabine—Pollakiuria—Doxorubicin—ovarian cancer	0.000296	0.000533	CcSEcCtD
Decitabine—Pain—Paclitaxel—ovarian cancer	0.000295	0.000531	CcSEcCtD
Decitabine—Constipation—Paclitaxel—ovarian cancer	0.000295	0.000531	CcSEcCtD
Decitabine—Confusional state—Docetaxel—ovarian cancer	0.000295	0.00053	CcSEcCtD
Decitabine—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000292	0.000526	CcSEcCtD
Decitabine—Oedema—Docetaxel—ovarian cancer	0.000292	0.000526	CcSEcCtD
Decitabine—Anaphylactic shock—Docetaxel—ovarian cancer	0.000292	0.000526	CcSEcCtD
Decitabine—Epistaxis—Epirubicin—ovarian cancer	0.000292	0.000525	CcSEcCtD
Decitabine—Infection—Docetaxel—ovarian cancer	0.00029	0.000523	CcSEcCtD
Decitabine—Weight decreased—Doxorubicin—ovarian cancer	0.00029	0.000522	CcSEcCtD
Decitabine—Sinusitis—Epirubicin—ovarian cancer	0.00029	0.000522	CcSEcCtD
Decitabine—Hyperglycaemia—Doxorubicin—ovarian cancer	0.000289	0.000521	CcSEcCtD
Decitabine—Pneumonia—Doxorubicin—ovarian cancer	0.000288	0.000518	CcSEcCtD
Decitabine—Nervous system disorder—Docetaxel—ovarian cancer	0.000287	0.000516	CcSEcCtD
Decitabine—Thrombocytopenia—Docetaxel—ovarian cancer	0.000286	0.000515	CcSEcCtD
Decitabine—Infestation—Doxorubicin—ovarian cancer	0.000286	0.000515	CcSEcCtD
Decitabine—Infestation NOS—Doxorubicin—ovarian cancer	0.000286	0.000515	CcSEcCtD
Decitabine—Tachycardia—Docetaxel—ovarian cancer	0.000285	0.000513	CcSEcCtD
Decitabine—Feeling abnormal—Paclitaxel—ovarian cancer	0.000284	0.000511	CcSEcCtD
Decitabine—Skin disorder—Docetaxel—ovarian cancer	0.000284	0.000511	CcSEcCtD
Decitabine—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000282	0.000508	CcSEcCtD
Decitabine—Renal failure—Doxorubicin—ovarian cancer	0.000281	0.000506	CcSEcCtD
Decitabine—Haemoglobin—Epirubicin—ovarian cancer	0.000279	0.000502	CcSEcCtD
Decitabine—Stomatitis—Doxorubicin—ovarian cancer	0.000279	0.000502	CcSEcCtD
Decitabine—Anorexia—Docetaxel—ovarian cancer	0.000279	0.000501	CcSEcCtD
Decitabine—Urinary tract infection—Doxorubicin—ovarian cancer	0.000278	0.0005	CcSEcCtD
Decitabine—Haemorrhage—Epirubicin—ovarian cancer	0.000278	0.000499	CcSEcCtD
Decitabine—Hypoaesthesia—Epirubicin—ovarian cancer	0.000276	0.000497	CcSEcCtD
Decitabine—Pharyngitis—Epirubicin—ovarian cancer	0.000276	0.000496	CcSEcCtD
Decitabine—Urinary tract disorder—Epirubicin—ovarian cancer	0.000274	0.000493	CcSEcCtD
Decitabine—Urticaria—Paclitaxel—ovarian cancer	0.000274	0.000493	CcSEcCtD
Decitabine—Oedema peripheral—Epirubicin—ovarian cancer	0.000273	0.000492	CcSEcCtD
Decitabine—Hypotension—Docetaxel—ovarian cancer	0.000273	0.000492	CcSEcCtD
Decitabine—Connective tissue disorder—Epirubicin—ovarian cancer	0.000273	0.000491	CcSEcCtD
Decitabine—Abdominal pain—Paclitaxel—ovarian cancer	0.000273	0.000491	CcSEcCtD
Decitabine—Body temperature increased—Paclitaxel—ovarian cancer	0.000273	0.000491	CcSEcCtD
Decitabine—Urethral disorder—Epirubicin—ovarian cancer	0.000272	0.00049	CcSEcCtD
Decitabine—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000271	0.000487	CcSEcCtD
Decitabine—DNMT3A—Gene Expression—ESR1—ovarian cancer	0.000271	0.00159	CbGpPWpGaD
Decitabine—Epistaxis—Doxorubicin—ovarian cancer	0.00027	0.000486	CcSEcCtD
Decitabine—Sinusitis—Doxorubicin—ovarian cancer	0.000268	0.000483	CcSEcCtD
Decitabine—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000266	0.000479	CcSEcCtD
Decitabine—Insomnia—Docetaxel—ovarian cancer	0.000264	0.000476	CcSEcCtD
Decitabine—Dyspnoea—Docetaxel—ovarian cancer	0.000261	0.000469	CcSEcCtD
Decitabine—Eye disorder—Epirubicin—ovarian cancer	0.000259	0.000467	CcSEcCtD
Decitabine—Haemoglobin—Doxorubicin—ovarian cancer	0.000258	0.000465	CcSEcCtD
Decitabine—DNMT1—Gene Expression—PPP2R1A—ovarian cancer	0.000258	0.00152	CbGpPWpGaD
Decitabine—Cardiac disorder—Epirubicin—ovarian cancer	0.000258	0.000464	CcSEcCtD
Decitabine—Dyspepsia—Docetaxel—ovarian cancer	0.000257	0.000463	CcSEcCtD
Decitabine—Haemorrhage—Doxorubicin—ovarian cancer	0.000257	0.000462	CcSEcCtD
Decitabine—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000256	0.00046	CcSEcCtD
Decitabine—Pharyngitis—Doxorubicin—ovarian cancer	0.000255	0.000459	CcSEcCtD
Decitabine—Decreased appetite—Docetaxel—ovarian cancer	0.000254	0.000457	CcSEcCtD
Decitabine—Hypersensitivity—Paclitaxel—ovarian cancer	0.000254	0.000457	CcSEcCtD
Decitabine—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000254	0.000456	CcSEcCtD
Decitabine—Oedema peripheral—Doxorubicin—ovarian cancer	0.000253	0.000455	CcSEcCtD
Decitabine—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000252	0.000454	CcSEcCtD
Decitabine—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000252	0.000454	CcSEcCtD
Decitabine—DCK—Metabolism—YAP1—ovarian cancer	0.000252	0.00148	CbGpPWpGaD
Decitabine—Fatigue—Docetaxel—ovarian cancer	0.000252	0.000454	CcSEcCtD
Decitabine—Angiopathy—Epirubicin—ovarian cancer	0.000252	0.000453	CcSEcCtD
Decitabine—Urethral disorder—Doxorubicin—ovarian cancer	0.000252	0.000453	CcSEcCtD
Decitabine—Immune system disorder—Epirubicin—ovarian cancer	0.000251	0.000451	CcSEcCtD
Decitabine—Mediastinal disorder—Epirubicin—ovarian cancer	0.00025	0.00045	CcSEcCtD
Decitabine—Constipation—Docetaxel—ovarian cancer	0.00025	0.00045	CcSEcCtD
Decitabine—Pain—Docetaxel—ovarian cancer	0.00025	0.00045	CcSEcCtD
Decitabine—Chills—Epirubicin—ovarian cancer	0.000249	0.000448	CcSEcCtD
Decitabine—Asthenia—Paclitaxel—ovarian cancer	0.000248	0.000445	CcSEcCtD
Decitabine—Alopecia—Epirubicin—ovarian cancer	0.000245	0.000441	CcSEcCtD
Decitabine—Pruritus—Paclitaxel—ovarian cancer	0.000244	0.000439	CcSEcCtD
Decitabine—Mental disorder—Epirubicin—ovarian cancer	0.000243	0.000438	CcSEcCtD
Decitabine—Malnutrition—Epirubicin—ovarian cancer	0.000242	0.000435	CcSEcCtD
Decitabine—Erythema—Epirubicin—ovarian cancer	0.000242	0.000435	CcSEcCtD
Decitabine—Feeling abnormal—Docetaxel—ovarian cancer	0.000241	0.000434	CcSEcCtD
Decitabine—Eye disorder—Doxorubicin—ovarian cancer	0.00024	0.000432	CcSEcCtD
Decitabine—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000239	0.00043	CcSEcCtD
Decitabine—Cardiac disorder—Doxorubicin—ovarian cancer	0.000238	0.000429	CcSEcCtD
Decitabine—Diarrhoea—Paclitaxel—ovarian cancer	0.000236	0.000425	CcSEcCtD
Decitabine—Back pain—Epirubicin—ovarian cancer	0.000234	0.000421	CcSEcCtD
Decitabine—Angiopathy—Doxorubicin—ovarian cancer	0.000233	0.000419	CcSEcCtD
Decitabine—Muscle spasms—Epirubicin—ovarian cancer	0.000232	0.000418	CcSEcCtD
Decitabine—Immune system disorder—Doxorubicin—ovarian cancer	0.000232	0.000417	CcSEcCtD
Decitabine—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000231	0.000417	CcSEcCtD
Decitabine—Abdominal pain—Docetaxel—ovarian cancer	0.000231	0.000416	CcSEcCtD
Decitabine—Body temperature increased—Docetaxel—ovarian cancer	0.000231	0.000416	CcSEcCtD
Decitabine—Chills—Doxorubicin—ovarian cancer	0.00023	0.000415	CcSEcCtD
Decitabine—Dizziness—Paclitaxel—ovarian cancer	0.000228	0.00041	CcSEcCtD
Decitabine—Vision blurred—Epirubicin—ovarian cancer	0.000228	0.00041	CcSEcCtD
Decitabine—Alopecia—Doxorubicin—ovarian cancer	0.000227	0.000408	CcSEcCtD
Decitabine—Mental disorder—Doxorubicin—ovarian cancer	0.000225	0.000405	CcSEcCtD
Decitabine—Ill-defined disorder—Epirubicin—ovarian cancer	0.000224	0.000403	CcSEcCtD
Decitabine—Malnutrition—Doxorubicin—ovarian cancer	0.000224	0.000402	CcSEcCtD
Decitabine—Erythema—Doxorubicin—ovarian cancer	0.000224	0.000402	CcSEcCtD
Decitabine—Anaemia—Epirubicin—ovarian cancer	0.000223	0.000402	CcSEcCtD
Decitabine—Vomiting—Paclitaxel—ovarian cancer	0.000219	0.000395	CcSEcCtD
Decitabine—Malaise—Epirubicin—ovarian cancer	0.000218	0.000392	CcSEcCtD
Decitabine—Rash—Paclitaxel—ovarian cancer	0.000218	0.000391	CcSEcCtD
Decitabine—Dermatitis—Paclitaxel—ovarian cancer	0.000217	0.000391	CcSEcCtD
Decitabine—Leukopenia—Epirubicin—ovarian cancer	0.000216	0.000389	CcSEcCtD
Decitabine—Back pain—Doxorubicin—ovarian cancer	0.000216	0.000389	CcSEcCtD
Decitabine—Headache—Paclitaxel—ovarian cancer	0.000216	0.000389	CcSEcCtD
Decitabine—Hypersensitivity—Docetaxel—ovarian cancer	0.000215	0.000388	CcSEcCtD
Decitabine—Muscle spasms—Doxorubicin—ovarian cancer	0.000215	0.000387	CcSEcCtD
Decitabine—Cough—Epirubicin—ovarian cancer	0.000211	0.000379	CcSEcCtD
Decitabine—Vision blurred—Doxorubicin—ovarian cancer	0.000211	0.000379	CcSEcCtD
Decitabine—Asthenia—Docetaxel—ovarian cancer	0.00021	0.000377	CcSEcCtD
Decitabine—Hypertension—Epirubicin—ovarian cancer	0.000209	0.000375	CcSEcCtD
Decitabine—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000207	0.000373	CcSEcCtD
Decitabine—Pruritus—Docetaxel—ovarian cancer	0.000207	0.000372	CcSEcCtD
Decitabine—Anaemia—Doxorubicin—ovarian cancer	0.000207	0.000372	CcSEcCtD
Decitabine—Arthralgia—Epirubicin—ovarian cancer	0.000206	0.00037	CcSEcCtD
Decitabine—Chest pain—Epirubicin—ovarian cancer	0.000206	0.00037	CcSEcCtD
Decitabine—Myalgia—Epirubicin—ovarian cancer	0.000206	0.00037	CcSEcCtD
Decitabine—DCK—Metabolism—FASN—ovarian cancer	0.000206	0.00121	CbGpPWpGaD
Decitabine—Anxiety—Epirubicin—ovarian cancer	0.000205	0.000369	CcSEcCtD
Decitabine—Nausea—Paclitaxel—ovarian cancer	0.000205	0.000369	CcSEcCtD
Decitabine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000204	0.000368	CcSEcCtD
Decitabine—Discomfort—Epirubicin—ovarian cancer	0.000203	0.000366	CcSEcCtD
Decitabine—DCK—Metabolism—SLC5A5—ovarian cancer	0.000202	0.00119	CbGpPWpGaD
Decitabine—Malaise—Doxorubicin—ovarian cancer	0.000202	0.000363	CcSEcCtD
Decitabine—Leukopenia—Doxorubicin—ovarian cancer	0.0002	0.00036	CcSEcCtD
Decitabine—Diarrhoea—Docetaxel—ovarian cancer	0.0002	0.00036	CcSEcCtD
Decitabine—Confusional state—Epirubicin—ovarian cancer	0.000199	0.000358	CcSEcCtD
Decitabine—Oedema—Epirubicin—ovarian cancer	0.000197	0.000355	CcSEcCtD
Decitabine—Anaphylactic shock—Epirubicin—ovarian cancer	0.000197	0.000355	CcSEcCtD
Decitabine—Infection—Epirubicin—ovarian cancer	0.000196	0.000353	CcSEcCtD
Decitabine—DCK—Metabolism—SLC2A1—ovarian cancer	0.000195	0.00115	CbGpPWpGaD
Decitabine—Cough—Doxorubicin—ovarian cancer	0.000195	0.000351	CcSEcCtD
Decitabine—Nervous system disorder—Epirubicin—ovarian cancer	0.000193	0.000348	CcSEcCtD
Decitabine—Dizziness—Docetaxel—ovarian cancer	0.000193	0.000348	CcSEcCtD
Decitabine—Thrombocytopenia—Epirubicin—ovarian cancer	0.000193	0.000347	CcSEcCtD
Decitabine—Hypertension—Doxorubicin—ovarian cancer	0.000193	0.000347	CcSEcCtD
Decitabine—Tachycardia—Epirubicin—ovarian cancer	0.000192	0.000346	CcSEcCtD
Decitabine—Skin disorder—Epirubicin—ovarian cancer	0.000192	0.000345	CcSEcCtD
Decitabine—Chest pain—Doxorubicin—ovarian cancer	0.00019	0.000343	CcSEcCtD
Decitabine—Arthralgia—Doxorubicin—ovarian cancer	0.00019	0.000343	CcSEcCtD
Decitabine—Myalgia—Doxorubicin—ovarian cancer	0.00019	0.000343	CcSEcCtD
Decitabine—Anxiety—Doxorubicin—ovarian cancer	0.00019	0.000341	CcSEcCtD
Decitabine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000189	0.00034	CcSEcCtD
Decitabine—Discomfort—Doxorubicin—ovarian cancer	0.000188	0.000338	CcSEcCtD
Decitabine—Anorexia—Epirubicin—ovarian cancer	0.000188	0.000338	CcSEcCtD
Decitabine—DCK—Metabolism—CYP1B1—ovarian cancer	0.000187	0.0011	CbGpPWpGaD
Decitabine—Vomiting—Docetaxel—ovarian cancer	0.000186	0.000335	CcSEcCtD
Decitabine—Rash—Docetaxel—ovarian cancer	0.000184	0.000332	CcSEcCtD
Decitabine—Hypotension—Epirubicin—ovarian cancer	0.000184	0.000332	CcSEcCtD
Decitabine—Dermatitis—Docetaxel—ovarian cancer	0.000184	0.000331	CcSEcCtD
Decitabine—Confusional state—Doxorubicin—ovarian cancer	0.000184	0.000331	CcSEcCtD
Decitabine—Headache—Docetaxel—ovarian cancer	0.000183	0.00033	CcSEcCtD
Decitabine—DNMT1—Gene Expression—ESR1—ovarian cancer	0.000183	0.00107	CbGpPWpGaD
Decitabine—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000182	0.000328	CcSEcCtD
Decitabine—Oedema—Doxorubicin—ovarian cancer	0.000182	0.000328	CcSEcCtD
Decitabine—Infection—Doxorubicin—ovarian cancer	0.000181	0.000326	CcSEcCtD
Decitabine—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.00018	0.000323	CcSEcCtD
Decitabine—Nervous system disorder—Doxorubicin—ovarian cancer	0.000179	0.000322	CcSEcCtD
Decitabine—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000179	0.000321	CcSEcCtD
Decitabine—Insomnia—Epirubicin—ovarian cancer	0.000178	0.000321	CcSEcCtD
Decitabine—Tachycardia—Doxorubicin—ovarian cancer	0.000178	0.00032	CcSEcCtD
Decitabine—Skin disorder—Doxorubicin—ovarian cancer	0.000177	0.000319	CcSEcCtD
Decitabine—Dyspnoea—Epirubicin—ovarian cancer	0.000176	0.000316	CcSEcCtD
Decitabine—Anorexia—Doxorubicin—ovarian cancer	0.000174	0.000313	CcSEcCtD
Decitabine—Nausea—Docetaxel—ovarian cancer	0.000174	0.000313	CcSEcCtD
Decitabine—Dyspepsia—Epirubicin—ovarian cancer	0.000174	0.000312	CcSEcCtD
Decitabine—Decreased appetite—Epirubicin—ovarian cancer	0.000171	0.000308	CcSEcCtD
Decitabine—Hypotension—Doxorubicin—ovarian cancer	0.000171	0.000307	CcSEcCtD
Decitabine—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.00017	0.000306	CcSEcCtD
Decitabine—Fatigue—Epirubicin—ovarian cancer	0.00017	0.000306	CcSEcCtD
Decitabine—Pain—Epirubicin—ovarian cancer	0.000169	0.000303	CcSEcCtD
Decitabine—Constipation—Epirubicin—ovarian cancer	0.000169	0.000303	CcSEcCtD
Decitabine—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000166	0.000299	CcSEcCtD
Decitabine—DCK—Metabolism—PPP2R1A—ovarian cancer	0.000166	0.000976	CbGpPWpGaD
Decitabine—Insomnia—Doxorubicin—ovarian cancer	0.000165	0.000297	CcSEcCtD
Decitabine—Dyspnoea—Doxorubicin—ovarian cancer	0.000163	0.000293	CcSEcCtD
Decitabine—Feeling abnormal—Epirubicin—ovarian cancer	0.000163	0.000292	CcSEcCtD
Decitabine—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000161	0.00029	CcSEcCtD
Decitabine—Dyspepsia—Doxorubicin—ovarian cancer	0.000161	0.000289	CcSEcCtD
Decitabine—Decreased appetite—Doxorubicin—ovarian cancer	0.000159	0.000285	CcSEcCtD
Decitabine—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000158	0.000283	CcSEcCtD
Decitabine—Fatigue—Doxorubicin—ovarian cancer	0.000157	0.000283	CcSEcCtD
Decitabine—Urticaria—Epirubicin—ovarian cancer	0.000157	0.000282	CcSEcCtD
Decitabine—Constipation—Doxorubicin—ovarian cancer	0.000156	0.000281	CcSEcCtD
Decitabine—Pain—Doxorubicin—ovarian cancer	0.000156	0.000281	CcSEcCtD
Decitabine—Body temperature increased—Epirubicin—ovarian cancer	0.000156	0.000281	CcSEcCtD
Decitabine—Abdominal pain—Epirubicin—ovarian cancer	0.000156	0.000281	CcSEcCtD
Decitabine—DCK—Metabolism—ABCB1—ovarian cancer	0.000154	0.000906	CbGpPWpGaD
Decitabine—DCK—Metabolism—TYMS—ovarian cancer	0.000152	0.00089	CbGpPWpGaD
Decitabine—Feeling abnormal—Doxorubicin—ovarian cancer	0.00015	0.000271	CcSEcCtD
Decitabine—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000149	0.000268	CcSEcCtD
Decitabine—Hypersensitivity—Epirubicin—ovarian cancer	0.000145	0.000261	CcSEcCtD
Decitabine—Urticaria—Doxorubicin—ovarian cancer	0.000145	0.000261	CcSEcCtD
Decitabine—DNMT3A—Gene Expression—MAPK3—ovarian cancer	0.000145	0.00085	CbGpPWpGaD
Decitabine—Body temperature increased—Doxorubicin—ovarian cancer	0.000144	0.00026	CcSEcCtD
Decitabine—Abdominal pain—Doxorubicin—ovarian cancer	0.000144	0.00026	CcSEcCtD
Decitabine—Asthenia—Epirubicin—ovarian cancer	0.000142	0.000255	CcSEcCtD
Decitabine—DNMT3A—Gene Expression—MYC—ovarian cancer	0.000141	0.000827	CbGpPWpGaD
Decitabine—Pruritus—Epirubicin—ovarian cancer	0.00014	0.000251	CcSEcCtD
Decitabine—Diarrhoea—Epirubicin—ovarian cancer	0.000135	0.000243	CcSEcCtD
Decitabine—Hypersensitivity—Doxorubicin—ovarian cancer	0.000134	0.000242	CcSEcCtD
Decitabine—Asthenia—Doxorubicin—ovarian cancer	0.000131	0.000236	CcSEcCtD
Decitabine—Dizziness—Epirubicin—ovarian cancer	0.00013	0.000235	CcSEcCtD
Decitabine—Pruritus—Doxorubicin—ovarian cancer	0.000129	0.000232	CcSEcCtD
Decitabine—Vomiting—Epirubicin—ovarian cancer	0.000125	0.000226	CcSEcCtD
Decitabine—Diarrhoea—Doxorubicin—ovarian cancer	0.000125	0.000225	CcSEcCtD
Decitabine—Rash—Epirubicin—ovarian cancer	0.000124	0.000224	CcSEcCtD
Decitabine—Dermatitis—Epirubicin—ovarian cancer	0.000124	0.000224	CcSEcCtD
Decitabine—Headache—Epirubicin—ovarian cancer	0.000124	0.000222	CcSEcCtD
Decitabine—DCK—Metabolism—CAV1—ovarian cancer	0.000122	0.000717	CbGpPWpGaD
Decitabine—Dizziness—Doxorubicin—ovarian cancer	0.000121	0.000217	CcSEcCtD
Decitabine—Nausea—Epirubicin—ovarian cancer	0.000117	0.000211	CcSEcCtD
Decitabine—Vomiting—Doxorubicin—ovarian cancer	0.000116	0.000209	CcSEcCtD
Decitabine—Rash—Doxorubicin—ovarian cancer	0.000115	0.000207	CcSEcCtD
Decitabine—Dermatitis—Doxorubicin—ovarian cancer	0.000115	0.000207	CcSEcCtD
Decitabine—Headache—Doxorubicin—ovarian cancer	0.000114	0.000206	CcSEcCtD
Decitabine—DCK—Metabolism—PIK3CG—ovarian cancer	0.000111	0.000653	CbGpPWpGaD
Decitabine—Nausea—Doxorubicin—ovarian cancer	0.000108	0.000195	CcSEcCtD
Decitabine—DCK—Metabolism—PIK3CD—ovarian cancer	9.78e-05	0.000574	CbGpPWpGaD
Decitabine—DNMT1—Gene Expression—MAPK3—ovarian cancer	9.77e-05	0.000574	CbGpPWpGaD
Decitabine—DNMT3A—Gene Expression—AKT1—ovarian cancer	9.76e-05	0.000573	CbGpPWpGaD
Decitabine—DNMT1—Gene Expression—MYC—ovarian cancer	9.51e-05	0.000558	CbGpPWpGaD
Decitabine—DCK—Metabolism—PIK3CB—ovarian cancer	8.52e-05	0.000501	CbGpPWpGaD
Decitabine—DCK—Metabolism—PTEN—ovarian cancer	7.36e-05	0.000433	CbGpPWpGaD
Decitabine—DNMT1—Gene Expression—AKT1—ovarian cancer	6.59e-05	0.000387	CbGpPWpGaD
Decitabine—DCK—Metabolism—PIK3CA—ovarian cancer	5.19e-05	0.000305	CbGpPWpGaD
Decitabine—DCK—Metabolism—AKT1—ovarian cancer	4.24e-05	0.000249	CbGpPWpGaD
